Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jaye Thompson Insider Profile
4 Followers
Jaye Thompson, SVP Clinical Dev & Reg Affairs at Acer Therapeutics, holds 264.15K shares in Greenwich LifeSciences (Ticker: GLSI), holds 4.31K shares in Acer Therapeutics (Ticker: ACER), holds 0.00 shares in Repros (Ticker: ~RPRX). Most recently, Jaye Thompson Bought ― shares of Greenwich LifeSciences on Nov 25, 2024 for an estimated value of 12.91K.
Jaye Thompson Acer Therapeutics (ACER)SVP Clinical Dev & Reg Affairs
Acer Therapeutics (ACER)
SVP Clinical Dev & Reg Affairs
Ranked #57,870 out of 100,202 Corporate Insiders
Profitable Transactions
6 out of 21 Profitable Transactions
Average Return
-1.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
VP Clinical Reg Affairs
Roles that Jaye Thompson holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 17, 2023 - Jul 17, 2024
Return:+72.20%
The most profitable trade made by Jaye Thompson
Jaye Thompson's Trading History
Acer Therapeutics
Nov 30, 2009
―
Uninformative Buy
―
$2.85K
Greenwich LifeSciences
Nov 25, 2024
VP Clinical Reg Affairs
Informative Buy
12.91K
$3.27M
Repros
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Jaye Thompson's performance on stock
You May Also Like
Jaye Thompson insider profile FAQ
What is the percentage of profitable transactions made by Jaye Thompson?
The percentage of profitable transactions made by Jaye Thompson is 29%.
What is the average return per transaction made by Jaye Thompson?
The average return per transaction made by Jaye Thompson is -1.90%.
What stocks does Jaye Thompson hold?
Jaye Thompson holds: ACER, GLSI, ~RPRX stocks.
What was Jaye Thompson’s latest transaction?
Jaye Thompson latest transaction was an Informative Buy of $12.91K.
What was Jaye Thompson's most profitable transaction?
Jaye Thompson’s most profitable transaction was an Informative Buy of GLSI stock on July 17, 2023. The return on the trade was 72.20%.
What is Jaye Thompson's role in Acer Therapeutics?
Jaye Thompson's role in Acer Therapeutics is SVP Clinical Dev & Reg Affairs.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.